{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T16:42:45Z","timestamp":1786207365515,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"MSH-UHN Academic Medical Organization Innovation Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1245\/s10434-026-19991-6","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:46:16Z","timestamp":1781718376000},"page":"8259-8266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Two-Year Outcomes after Direct-to-Surgery in Good Prognosis Margin-Clear Stage II or III Rectal Cancer: The QuickSilver Study"],"prefix":"10.1245","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0707-5294","authenticated-orcid":false,"given":"Erin D.","family":"Kennedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Simunovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Schmocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Pooni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony R.","family":"MacLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sender","family":"Liberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Drolet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stotland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Kopek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Burkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Pond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy N.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The Rectal Cancer Alliance of Canada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"key":"19991_CR1","doi-asserted-by":"publisher","first-page":"366","DOI":"10.6004\/jnccn.2024.0041","volume":"22","author":"AB Benson","year":"2024","unstructured":"Benson AB, Venook AP, Adam M, et al. NCCN Guidelines(R) insights: rectal cancer Version 3.2024. J Natl Compr Canc Netw. 2024;22:366\u201375.","journal-title":"J Natl Compr Canc Netw."},{"key":"19991_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/DCR.0000000000003057","volume":"67","author":"SJ Langenfeld","year":"2024","unstructured":"Langenfeld SJ, Davis BR, Vogel JD, et al. The American society of colon and rectal surgeons clinical practice guidelines for the management of rectal cancer 2023 supplement. Dis Colon Rectum. 2024;67:18\u201331.","journal-title":"Dis Colon Rectum."},{"key":"19991_CR3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.clon.2015.01.001","volume":"27","author":"E Kennedy","year":"2015","unstructured":"Kennedy E, Vella ET, Blair Macdonald D, Wong CS, McLeod R. Cancer care ontario preoperative assessment for rectal cancer guideline development G. Optimisation of preoperative assessment in patients diagnosed with rectal cancer. Clin Oncol (R Coll Radiol). 2015;27:225.","journal-title":"Clin Oncol (R Coll Radiol)."},{"key":"19991_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.clon.2010.03.002","volume":"22","author":"RK Wong","year":"2010","unstructured":"Wong RK, Berry S, Spithoff K, et al. Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline. Clin Oncol (R Coll Radiol). 2010;22:265\u201371.","journal-title":"Clin Oncol (R Coll Radiol)."},{"key":"19991_CR5","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","volume":"22","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:702\u201315.","journal-title":"Lancet Oncol."},{"key":"19991_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:29\u201342.","journal-title":"Lancet Oncol."},{"key":"19991_CR7","doi-asserted-by":"publisher","first-page":"6199","DOI":"10.1200\/JCO.2005.14.779","volume":"23","author":"KC Peeters","year":"2005","unstructured":"Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients\u2013a Dutch colorectal cancer group study. J Clin Oncol. 2005;23:6199\u2013206.","journal-title":"J Clin Oncol."},{"key":"19991_CR8","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1200\/JCO.2005.05.256","volume":"23","author":"CA Marijnen","year":"2005","unstructured":"Marijnen CA, van de Velde CJ, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2005;23:1847\u201358.","journal-title":"J Clin Oncol."},{"key":"19991_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00520-021-06502-4","volume":"30","author":"C Teng","year":"2022","unstructured":"Teng C, Cohen J, Egger S, Blinman PL, Vardy JL. Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer. Support Care Cancer. 2022;30:33\u201347.","journal-title":"Support Care Cancer."},{"key":"19991_CR10","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1056\/NEJMoa010580","volume":"345","author":"E Kapiteijn","year":"2001","unstructured":"Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638\u201346.","journal-title":"N Engl J Med."},{"key":"19991_CR11","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","volume":"373","author":"D Sebag-Montefiore","year":"2009","unstructured":"Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811\u201320.","journal-title":"Lancet."},{"key":"19991_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/jso.21395","volume":"101","author":"AJ Smith","year":"2010","unstructured":"Smith AJ, Driman DK, Spithoff K, et al. Guideline for optimization of colorectal cancer surgery and pathology. J Surg Oncol. 2010;101:5\u201312.","journal-title":"J Surg Oncol."},{"key":"19991_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa2303269","volume":"389","author":"D Schrag","year":"2023","unstructured":"Schrag D, Shi Q, Weiser MR, et al. Preoperative treatment of locally advanced rectal cancer. N Engl J Med. 2023;389:322\u201334.","journal-title":"N Engl J Med."},{"key":"19991_CR14","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/SLA.0b013e31820b8d52","volume":"253","author":"FG Taylor","year":"2011","unstructured":"Taylor FG, Quirke P, Heald RJ, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter. European study Ann Surg. 2011;253:711\u20139.","journal-title":"European study. Ann Surg."},{"key":"19991_CR15","doi-asserted-by":"publisher","unstructured":"Ruppert R, Junginger T, Ptok H, et al. Oncological outcome after MRI-based selection for neoadjuvant chemoradiotherapy in the OCUM Rectal Cancer Trial. Br J Surg. 2018. https:\/\/doi.org\/10.1002\/bjs.10879","DOI":"10.1002\/bjs.10879"},{"key":"19991_CR16","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaoncol.2019.0186","volume":"5","author":"ED Kennedy","year":"2019","unstructured":"Kennedy ED, Simunovic M, Jhaveri K, et al. Safety and feasibility of using magnetic resonance imaging criteria to identify patients with \u201cgood prognosis\u201d rectal cancer eligible for primary surgery: the Phase 2 Nonrandomized QuickSilver Clinical Trial. JAMA Oncol. 2019;5:961\u20136.","journal-title":"JAMA Oncol."},{"key":"19991_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1741-7015-8-18","volume":"8","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18.","journal-title":"BMC Med."},{"key":"19991_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(09)60485-2","volume":"373","author":"P Quirke","year":"2009","unstructured":"Quirke P, Steele R, Monson J, et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet. 2009;373:821\u20138.","journal-title":"Lancet."},{"key":"19991_CR19","unstructured":"College of American Pathologists - Cancer Protocols and Checklists. Colon and Rectum. Available from URL:."},{"key":"19991_CR20","volume-title":"Fundamentals of Biostatistics","author":"B Rosner","year":"1995","unstructured":"Rosner B. Fundamentals of Biostatistics. 4th edn. USA: Duxbury Press, A Division of International Thompson Publishing Inc; 1995.","edition":"4"},{"key":"19991_CR21","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1200\/JCO.22.02166","volume":"41","author":"R Ruppert","year":"2023","unstructured":"Ruppert R, Junginger T, Kube R, et al. Risk-adapted neoadjuvant chemoradiotherapy in rectal cancer: final report of the OCUM Study. J Clin Oncol. 2023;41:4025\u201334.","journal-title":"J Clin Oncol."},{"key":"19991_CR22","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1097\/SLA.0000000000003649","volume":"272","author":"X Deng","year":"2020","unstructured":"Deng X, Liu P, Jiang D, et al. Neoadjuvant radiotherapy versus surgery alone for stage II\/III mid-low rectal cancer with or without high-risk factors: a prospective multicenter stratified randomized trial. Ann Surg. 2020;272:1060\u20139.","journal-title":"Ann Surg."},{"key":"19991_CR23","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1503\/cjs.009417","volume":"61","author":"M Simunovic","year":"2018","unstructured":"Simunovic M, Grubac V, Zbuk K, Wong R, Coates A. Role of the status of the mesorectal fascia in the selection of patients with rectal cancer for preoperative radiation therapy: a retrospective cohort study. Can J Surg. 2018;61:332\u20138.","journal-title":"Can J Surg."},{"key":"19991_CR24","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1245\/s10434-011-2210-5","volume":"19","author":"E Al-Sukhni","year":"2012","unstructured":"Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19:2212\u201323.","journal-title":"Ann Surg Oncol."},{"key":"19991_CR25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1200\/JCO.21.01667","volume":"40","author":"J Jin","year":"2022","unstructured":"Jin J, Tang Y, Hu C, et al. Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol. 2022;40:1681\u201392.","journal-title":"J Clin Oncol."},{"key":"19991_CR26","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1001\/jama.294.20.2587","volume":"294","author":"NN Baxter","year":"2005","unstructured":"Baxter NN, Habermann EB, Tepper JE, Durham SB, Virnig BA. Risk of pelvic fractures in older women following pelvic irradiation. JAMA. 2005;294:2587\u201393.","journal-title":"JAMA."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19991-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-19991-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-19991-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:48:58Z","timestamp":1786204138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-026-19991-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["19991"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-19991-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was supported by the MSH-UHN Academic Medical Organization Innovation Fund. G.R.P. received consulting fees from Traferox Technologies and Calian CRO.","order":1,"name":"Ethics","label":"Financial Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}}]}}